trial

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

NCTId NCT02916810
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 140 (estimated)
Sponsored by The University of Texas Health Science Center, Houston
Primary completion 2029-07-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
140 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2025-02-01
Primary completion
2029-07-01
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
Active rTMS stimulation

Sponsors

The University of Texas Health Science Center, HoustonLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Xiaoming Du, PhDPrincipal Investigator

Sites

1 total
Houston, United States

Facts & assertions

4 sourced
Enrollment
140
Phase
NA
Primary Completion Date
2029-07-01
Status
RECRUITING
relationships
The graph out of here
drug
Active rTMS stimulation
drug
lead_sponsor
The University of Texas Health Science Center, Houston
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia and Related Disorders
indication
Schizophrenia
indication
investigator
Xiaoming Du, PhD
person